Biodefense is the use of medical measures to protect people against bioterrorism. It mainly applies to two different target populations, namely military combatant (troops in the field) and civilian non-combatant. The protection of food supplies and water are often considered a critical part of biodefense. Owing to the increasing threat of terrorism and bioterrorism, the risk posed by exposure to biological agents that can be used as biological weapons must be evaluated. Biological agents used in warfare may prove to be more potent than conventional weapons. In the last century, the developments made in biochemistry and biotechnology have simplified the production of such weapons. Genetic engineering can be used to create new pathogens by manipulating genes, thereby giving rise to a whole new generation of genetically modified bioweapons. Factors such as ease of production, availability of technical know-how, and the extensive accessibility of biological agents have further led to the threat of biological weapons.
The analysts forecast the global biodefense market to grow at a CAGR of 5.41% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global biodefense market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biodefense.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2605327-global-biodefense-market-2017-2021
The report, Global Biodefense market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Altimmune
• Bavarian Nordic
• DynPort Vaccine Company (DVC)
• Emergent BioSolutions
Other prominent vendors
• Acambis
• Achaogen
• Cleveland BioLabs
• Elusys Therapeutics
Market driver
• Growing threat of bioterrorism
• For a full, detailed list, view our report
Market challenge
• Lack of information about bioengineered organisms attack
• For a full, detailed list, view our report
Market trend
• Government initiatives
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
Any Query, Submit Here @ https://www.wiseguyreports.com/enquiry/2605327-global-biodefense-market-2017-2021
Table of Contents –Analysis of Key Points
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: MARKET LANDSCAPE
• Market overview
PART 06: FIVE FORCES ANALYSIS
• Five forces analysis
PART 07: MARKET SEGMENTATION BY APPLICATION
• Comparison by application
• Global biodefense against anthrax market
• Global biodefense against smallpox market
• Global biodefense against botulism market
• Global biodefense against others market
• Market opportunity
PART 08: REGIONAL LANDSCAPE
• Regional comparison
• Biodefense market in Americas
• Biodefense market in EMEA
• Biodefense market in APAC
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Government initiatives
• Growing collaborations and M&A
PART 12: VENDOR LANDSCAPE
• Competitive landscape
• Altimmune
• Bavarian Nordic
• DynPort Vaccine Company (DVC)
• Emergent BioSolutions
• Other prominent vendors
..…..Continued
Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt. Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349
Website: http://www.wiseguyreports.com
Release ID: 276549